However, in a different study, leptin levels decreased in subjects with overweight or obesity who followed an ADF protocol, but adiponectin levels did not change, nor did other biomarkers of inflammation, including resistin, IL-6, or TNF-α [62]. This evidence concerns the gene ADIPOQ and obesity disorder.